Logo image of SOLV.BR

SOLVAC SA-REG (SOLV.BR) Stock Fundamental Analysis

EBR:SOLV - Euronext Brussels - BE0003545531 - Common Stock - Currency: EUR

96.4  -1.2 (-1.23%)

Fundamental Rating

4

Overall SOLV gets a fundamental rating of 4 out of 10. We evaluated SOLV against 61 industry peers in the Chemicals industry. SOLV has a medium profitability rating, but doesn't score so well on its financial health evaluation. SOLV has a valuation in line with the averages, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

SOLV had positive earnings in the past year.
Of the past 5 years SOLV 4 years were profitable.
Of the past 5 years SOLV 4 years had a positive operating cash flow.
SOLV.BR Yearly Net Income VS EBIT VS OCF VS FCFSOLV.BR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 200M -200M

1.2 Ratios

SOLV has a Return On Assets of 7.35%. This is amongst the best in the industry. SOLV outperforms 84.13% of its industry peers.
With a decent Return On Equity value of 8.02%, SOLV is doing good in the industry, outperforming 69.84% of the companies in the same industry.
With a decent Return On Invested Capital value of 5.88%, SOLV is doing good in the industry, outperforming 71.43% of the companies in the same industry.
SOLV had an Average Return On Invested Capital over the past 3 years of 4.78%. This is in line with the industry average of 6.72%.
The last Return On Invested Capital (5.88%) for SOLV is above the 3 year average (4.78%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 7.35%
ROE 8.02%
ROIC 5.88%
ROA(3y)6.13%
ROA(5y)1.53%
ROE(3y)6.62%
ROE(5y)1.63%
ROIC(3y)4.78%
ROIC(5y)N/A
SOLV.BR Yearly ROA, ROE, ROICSOLV.BR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 5 -5 10 -10

1.3 Margins

SOLV has a better Profit Margin (94.76%) than 100.00% of its industry peers.
SOLV's Profit Margin has been stable in the last couple of years.
SOLV has a better Operating Margin (98.11%) than 100.00% of its industry peers.
SOLV's Operating Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 98.11%
PM (TTM) 94.76%
GM N/A
OM growth 3Y-1.49%
OM growth 5Y-0.02%
PM growth 3Y-2.83%
PM growth 5Y-0.83%
GM growth 3YN/A
GM growth 5YN/A
SOLV.BR Yearly Profit, Operating, Gross MarginsSOLV.BR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 100 200 300 400

3

2. Health

2.1 Basic Checks

SOLV has about the same amout of shares outstanding than it did 1 year ago.
Compared to 5 years ago, SOLV has about the same amount of shares outstanding.
SOLV has a worse debt/assets ratio than last year.
SOLV.BR Yearly Shares OutstandingSOLV.BR Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M 20M
SOLV.BR Yearly Total Debt VS Total AssetsSOLV.BR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 1B 2B 3B

2.2 Solvency

An Altman-Z score of 6.59 indicates that SOLV is not in any danger for bankruptcy at the moment.
With an excellent Altman-Z score value of 6.59, SOLV belongs to the best of the industry, outperforming 98.41% of the companies in the same industry.
SOLV has a Debt/Equity ratio of 0.06. This is a healthy value indicating a solid balance between debt and equity.
SOLV has a better Debt to Equity ratio (0.06) than 93.65% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.06
Debt/FCF N/A
Altman-Z 6.59
ROIC/WACCN/A
WACCN/A
SOLV.BR Yearly LT Debt VS Equity VS FCFSOLV.BR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 1B 2B 3B

2.3 Liquidity

SOLV has a Current Ratio of 0.85. This is a bad value and indicates that SOLV is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Current ratio value of 0.85, SOLV is not doing good in the industry: 87.30% of the companies in the same industry are doing better.
A Quick Ratio of 0.85 indicates that SOLV may have some problems paying its short term obligations.
The Quick ratio of SOLV (0.85) is worse than 71.43% of its industry peers.
Industry RankSector Rank
Current Ratio 0.85
Quick Ratio 0.85
SOLV.BR Yearly Current Assets VS Current LiabilitesSOLV.BR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M

3

3. Growth

3.1 Past

The Earnings Per Share has been growing slightly by 1.17% over the past year.
The earnings per share for SOLV have been decreasing by -14.05% on average. This is quite bad
Looking at the last year, SOLV shows a small growth in Revenue. The Revenue has grown by 2.65% in the last year.
The Revenue for SOLV have been decreasing by -13.30% on average. This is quite bad
EPS 1Y (TTM)1.17%
EPS 3YN/A
EPS 5Y-14.05%
EPS Q2Q%-3.78%
Revenue 1Y (TTM)2.65%
Revenue growth 3YN/A
Revenue growth 5Y-13.3%
Sales Q2Q%-3.36%

3.2 Future

SOLV is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 1.18% yearly.
The Revenue is expected to grow by 3.37% on average over the next years.
EPS Next Y-4.03%
EPS Next 2Y1.18%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year3.06%
Revenue Next 2Y3.37%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
SOLV.BR Yearly Revenue VS EstimatesSOLV.BR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5B 10B
SOLV.BR Yearly EPS VS EstimatesSOLV.BR Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10

5

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 10.14, which indicates a very decent valuation of SOLV.
Compared to the rest of the industry, the Price/Earnings ratio of SOLV indicates a rather cheap valuation: SOLV is cheaper than 93.65% of the companies listed in the same industry.
When comparing the Price/Earnings ratio of SOLV to the average of the S&P500 Index (29.35), we can say SOLV is valued rather cheaply.
A Price/Forward Earnings ratio of 6.64 indicates a rather cheap valuation of SOLV.
SOLV's Price/Forward Earnings ratio is rather cheap when compared to the industry. SOLV is cheaper than 98.41% of the companies in the same industry.
SOLV is valuated cheaply when we compare the Price/Forward Earnings ratio to 22.10, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 10.14
Fwd PE 6.64
SOLV.BR Price Earnings VS Forward Price EarningsSOLV.BR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
SOLV.BR Per share dataSOLV.BR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60 80 100

4.3 Compensation for Growth

The decent profitability rating of SOLV may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y1.18%
EPS Next 3YN/A

4

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 3.56%, SOLV has a reasonable but not impressive dividend return.
Compared to an average industry Dividend Yield of 2.89, SOLV pays a bit more dividend than its industry peers.
SOLV's Dividend Yield is rather good when compared to the S&P500 average which is at 2.33.
Industry RankSector Rank
Dividend Yield 3.56%

5.2 History

The dividend of SOLV has a limited annual growth rate of 2.15%.
Dividend Growth(5Y)2.15%
Div Incr Years2
Div Non Decr Years5
SOLV.BR Yearly Dividends per shareSOLV.BR Yearly Dividends per shareYearly Dividends per share 2018 2019 2020 2021 2022 2023 2024 2025 1 2 3 4 5

5.3 Sustainability

The dividend of SOLV is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP0%
EPS Next 2Y1.18%
EPS Next 3YN/A
SOLV.BR Yearly Income VS Free CF VS DividendSOLV.BR Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 200M -200M

SOLVAC SA-REG

EBR:SOLV (3/7/2025, 7:00:00 PM)

96.4

-1.2 (-1.23%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)03-07 2025-03-07
Earnings (Next)07-25 2025-07-25
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners5.24%
Ins Owner ChangeN/A
Market Cap2.06B
Analysts82.5
Price Target160.29 (66.28%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 3.56%
Yearly Dividend5.57
Dividend Growth(5Y)2.15%
DP0%
Div Incr Years2
Div Non Decr Years5
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 10.14
Fwd PE 6.64
P/S 9.61
P/FCF N/A
P/OCF N/A
P/B 0.81
P/tB 0.81
EV/EBITDA N/A
EPS(TTM)9.51
EY9.87%
EPS(NY)14.52
Fwd EY15.07%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS10.04
BVpS118.61
TBVpS118.61
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 7.35%
ROE 8.02%
ROCE 7.84%
ROIC 5.88%
ROICexc 5.99%
ROICexgc 5.99%
OM 98.11%
PM (TTM) 94.76%
GM N/A
FCFM N/A
ROA(3y)6.13%
ROA(5y)1.53%
ROE(3y)6.62%
ROE(5y)1.63%
ROIC(3y)4.78%
ROIC(5y)N/A
ROICexc(3y)4.78%
ROICexc(5y)N/A
ROICexgc(3y)5.25%
ROICexgc(5y)N/A
ROCE(3y)6.37%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5Y-9.66%
ROICexc growth 3YN/A
ROICexc growth 5Y-7.85%
OM growth 3Y-1.49%
OM growth 5Y-0.02%
PM growth 3Y-2.83%
PM growth 5Y-0.83%
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover0.08
Health
Industry RankSector Rank
Debt/Equity 0.06
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.85
Quick Ratio 0.85
Altman-Z 6.59
F-ScoreN/A
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)1.17%
EPS 3YN/A
EPS 5Y-14.05%
EPS Q2Q%-3.78%
EPS Next Y-4.03%
EPS Next 2Y1.18%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)2.65%
Revenue growth 3YN/A
Revenue growth 5Y-13.3%
Sales Q2Q%-3.36%
Revenue Next Year3.06%
Revenue Next 2Y3.37%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y2.28%
EBIT growth 3YN/A
EBIT growth 5Y-13.31%
EBIT Next Year33.92%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A